No Data
C HEALTH GP: ANNUAL REPORT FOR THE YEAR ENDED 31 DECEMBER 2025
C HEALTH GP: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2025
C HEALTH GP: POSTPONEMENT OF BOARD MEETING
China Medical Group (08225): Continuously making active efforts to recover outstanding payments and adopting differentiated strategies based on the varying circumstances of debtors.
China Healthcare Group (08225) announced that, as disclosed in the company’s '2024 Annual Report,' as of December 31, 2024, the total book value of the company's receivables amounted to RMB 128 million, with corresponding impairment provisions fully accrued in accordance with accounting standards. These amounts primarily arise from the group’s routine business operations and are considered standard industry practice.
China Medical Group (08225): Hengbo Capital Appointed as Independent Financial Advisor
China Healthcare Group (08225) announced that on December 10, 2025 (after trading hours), the company entered into a new framework service agreement with Mr. Guo Xia to extend the term of the 2022 Service Agreement; and set annual caps for the years ending December 31, 2025, December 31, 2026, and December 31, 2027.
C HEALTH GP: INTERIM REPORT FOR THE SIX MONTHS ENDED 30 JUNE 2025